Preanesthetic sedation. Sedative, hypnotic, or anxiolytic related disorders
Conditions
Interventions
Intervention 1: Intervention group: 0.5 mg/kg syrup Midazolam PO, 20 minutes prior parental separation to conducting anesthesia. Intervention 2: Intervention group: 0.2 mg/kg nasal spray Midazolam int
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
6 Months to 6 Years
Inclusion criteria
Inclusion criteria: The patient is classified as ASA class 1 to 2 according to the American Society of Anesthesiologists; The patient's age is between 6 months to 6 years; The patient is a candidate for MRI under anesthesia;
Exclusion criteria
Exclusion criteria: The patient has upper gastrointestinal tract problems; The patient has an active infection; The patient has structural disorders of the upper respiratory system; The patient is cyanotic; Having a history of drug allergy to benzodiazepines; Severe crying and restlessness of the child immediately before administering the medicine;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sedation scale. Timepoint: 0, 5, 10, 15 and 20 minutes after receiving the intervention. Method of measurement: Scoring system and clinical assessment. | — |
Secondary
| Measure | Time frame |
|---|---|
| Parental separation anxiety scale. Timepoint: 20 minutes after receiving the intervention. Method of measurement: Scoring system and clinical assessment.;Mask acceptance score. Timepoint: 20 minutes after receiving the intervention. Method of measurement: Scoring system and clinical assessment.;Recovery score. Timepoint: Recovery time. Method of measurement: Scoring system and clinical assessment.;Agitation score. Timepoint: At discharge. Method of measurement: Scoring system and clinical assessment. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAshkan Taghizadeh
Tehran University of Medical Sciences
Outcome results
None listed